EOFlow Initiates Eco-Frie...
▶EOFlow will collect, process, and dispose of used EOPatch pumps in an environmentally safe manner ▶EOFlow will set up an Incentive Program for this Campaign EOFlow Co., Ltd. (KOSDAQ: 294090) (EOFlow or the Company), a provider of wearable drug delivery solutions, announced today that the Company i...
Nov.09.2021
EOFlow to Raise 100 Billi...
▶ 100 billion Won to be raised with new common stock offering, to be followed by a 2:1 stock split EOFlow Co., Ltd. (KOSDAQ: 294090) (EOFlow or the Company), a provider of wearable drug delivery solutions, has announced today that the Company will raise some 100 billion Won with new common stock of...
Oct.28.2021
EOFlow and Sinocare Estab...
▶ Sinocare is China’s Largest Diabetes Management Instrument Manufacturer ▶ Joint venture company to launch a full-scale effort for clinical study to obtain regulatory approval for EOPatch manufacturing and distribution in China ▶ High growth expected from EOPatch business in China where world...
Oct.27.2021
EOFlow Begins Clinical St...
▶ This clinical study involves ten leading university hospitals and up to one hundred and thirty-six people with Type 2 diabetes. It is Korea’s largest ever clinical study employing insulin pumps. ▶ This pioneering study aims to demonstrate and validate efficacy of EOPatch for Type 2 diabetes ...
Oct.14.2021
EOFlow Completes its Firs...
▶ EOFlow’s European exclusive distributing partner Menarini to showcase the EOPatch at EASD 2021 EOFlow Co., Ltd. (KOSDAQ: 294090) (EOFlow or the Company), a provider of wearable drug delivery solutions, has made its first shipment to Europe today. After launching the wearable insulin ...
Sep.30.2021
EOFlow Celebrates its 10t...
▶ EOFlow held a virtual event to celebrate its 10th anniversary ▶ Aims to become a world’s leading wearable drug delivery solution provider EOFlow Co., Ltd. (KOSDAQ: 294090) (EOFlow or the Company), a provider of wearable drug delivery solutions, celebrates its 10th anniversary today. In mark...
Sep.27.2021
EOFlow Makes a Significan...
▶ Funding up to 18 billion KRW secured through loans from the Korea Development Bank ▶ Automation to reduce production costs and expand manufacturing capacity EOFlow (KOSDAQ: 294090) (EOFlow or the Company), a provider of wearable drug delivery solutions, today announced that it will make a large i...
Sep.06.2021
EOFlow Officially Launche...
▶ World’s first smartphone app for controlling wearable insulin pump ▶ Improved ease of use by replacing a portable device with a smartphone app ▶ EOPatch Online Education Center is now open to educate and promote benefits of wireless insulin management system EOFlow Co., Ltd. (KOSDAQ: 294090...
Aug.30.2021
EOFlow Signs Mutual Equit...
▶ EOFlow and UXN sign mutual equity investment agreement to strengthen mutual trust for future competitiveness ▶ Convergence of low-power electroosmotic pump with continuous blood glucose measurement technology for the development of two-part and integrated wearable artificial pancreas systems EOFl...
Aug.02.2021
[Medical Observer] New In...
Reporter Park from Medical Observer introduced EOFlow's wearable, disposable insulin pump EOPatch in the article today. (In Korean only: http://www.monews.co.kr/news/articleView.html?idxno=305824) At the bottom of the article, reporter Park introduced EOFlow as a company that suc...
Jul.30.2021
